<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">36271437</PMID><DateCompleted><Year>2023</Year><Month>02</Month><Day>14</Day></DateCompleted><DateRevised><Year>2023</Year><Month>02</Month><Day>14</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1537-2995</ISSN><JournalIssue CitedMedium="Internet"><Volume>63</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Transfusion</Title><ISOAbbreviation>Transfusion</ISOAbbreviation></Journal><ArticleTitle>A large cohort study of the effects of Lewis, ABO, 13 other blood groups, and secretor status on COVID-19 susceptibility, severity, and long COVID-19.</ArticleTitle><Pagination><StartPage>47</StartPage><EndPage>58</EndPage><MedlinePgn>47-58</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/trf.17170</ELocationID><Abstract><AbstractText Label="BACKGROUND">Previous studies have reported Blood type O to confer a lower risk of SARS-CoV-2 infection, while secretor status and other blood groups have been suspected to have a similar effect as well.</AbstractText><AbstractText Label="STUDY DESIGN AND METHODS">To determine whether any other blood groups influence testing positive for SARS-CoV-2, COVID-19 severity, or prolonged COVID-19, we used a large cohort of 650,156 Danish blood donors with varying available data for secretor status and blood groups ABO, Rh, Colton, Duffy, Diego, Dombrock, Kell, Kidd, Knops, Lewis, Lutheran, MNS, P1PK, Vel, and Yt. Of these, 36,068 tested positive for SARS-CoV-2 whereas 614,088 tested negative between 2020-02-17 and 2021-08-04. Associations between infection and blood groups were assessed using logistic regression models with sex and age as covariates.</AbstractText><AbstractText Label="RESULTS">The Lewis blood group antigen Le<sup>a</sup> displayed strongly reduced SARS-CoV-2 susceptibility OR 0.85 CI[0.79-0.93] p&#x2009;&lt;&#x2009;.001. Compared to blood type O, the blood types B, A, and AB were found more susceptible toward infection with ORs 1.1 CI[1.06-1.14] p&#x2009;&lt;&#x2009;.001, 1.17 CI[1.14-1.2] p&#x2009;&lt;&#x2009;.001, and 1.2 CI[1.14-1.26] p&#x2009;&lt;&#x2009;.001, respectively. No susceptibility associations were found for the other 13 blood groups investigated. There was no association between any blood groups and COVID-19 hospitalization or long COVID-19. No secretor status associations were found.</AbstractText><AbstractText Label="DISCUSSION">This study uncovers a new association to reduced SARS-CoV-2 susceptibility for Lewis type Le<sup>a</sup> and confirms the previous link to blood group O. The new association to Le<sup>a</sup> could be explained by a link between mucosal microbiome and SARS-CoV-2.</AbstractText><CopyrightInformation>&#xa9; 2022 The Authors. Transfusion published by Wiley Periodicals LLC on behalf of AABB.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Moslemi</LastName><ForeName>Camous</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0001-7905-9774</Identifier><AffiliationInfo><Affiliation>Department of Clinical Immunology, Zealand University Hospital, K&#xf8;ge, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Saekmose</LastName><ForeName>Susanne</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Clinical Immunology, Zealand University Hospital, K&#xf8;ge, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Larsen</LastName><ForeName>Rune</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Clinical Immunology, Zealand University Hospital, K&#xf8;ge, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brodersen</LastName><ForeName>Thorsten</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0003-4431-9972</Identifier><AffiliationInfo><Affiliation>Department of Clinical Immunology, Zealand University Hospital, K&#xf8;ge, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Didriksen</LastName><ForeName>Maria</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-4856-496X</Identifier><AffiliationInfo><Affiliation>Department of Clinical Immunology, Copenhagen University Hospital, Rigshopitalet, Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hjalgrim</LastName><ForeName>Henrik</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Clinical Immunology, Aarhus University Hospital, Skejby, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Banasik</LastName><ForeName>Karina</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Novo Nordisk Foundation Center for Protein Research, University of Copenhagen, Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nielsen</LastName><ForeName>Kaspar R</ForeName><Initials>KR</Initials><AffiliationInfo><Affiliation>Department of Clinical Immunology, Aalborg University Hospital, Aalborg, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bruun</LastName><ForeName>Mie T</ForeName><Initials>MT</Initials><AffiliationInfo><Affiliation>Department of Clinical Immunology, Odense University Hospital, Odense, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dowsett</LastName><ForeName>Joseph</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0001-5381-2633</Identifier><AffiliationInfo><Affiliation>Department of Clinical Immunology, Copenhagen University Hospital, Rigshopitalet, Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kasperen</LastName><ForeName>Kathrine A</ForeName><Initials>KA</Initials><AffiliationInfo><Affiliation>Danish Cancer Society Research Center, Copenhagen, Denmark.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Danish Big Data Centre for Environment and Health (BERTHA), Aarhus University, Roskilde, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mikkelsen</LastName><ForeName>Susan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Danish Cancer Society Research Center, Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hansen</LastName><ForeName>Thomas F</ForeName><Initials>TF</Initials><AffiliationInfo><Affiliation>Novo Nordisk Foundation Center for Protein Research, University of Copenhagen, Copenhagen, Denmark.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, NeuroGenomic group, Rigshospitalet, Glostrup, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ullum</LastName><ForeName>Henrik</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Statens Serum Institut, Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Erikstrup</LastName><ForeName>Christian</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Danish Cancer Society Research Center, Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Olsson</LastName><ForeName>Martin L</ForeName><Initials>ML</Initials><Identifier Source="ORCID">0000-0003-1647-9610</Identifier><AffiliationInfo><Affiliation>Department of Laboratory Medicine, Lund University, Lund, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Clinical Immunology and Transfusion Medicine, Office for Medical Services, Lund, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ostrowski</LastName><ForeName>Sisse R</ForeName><Initials>SR</Initials><AffiliationInfo><Affiliation>Department of Clinical Immunology, Copenhagen University Hospital, Rigshopitalet, Copenhagen, Denmark.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pedersen</LastName><ForeName>Ole B</ForeName><Initials>OB</Initials><AffiliationInfo><Affiliation>Department of Clinical Immunology, Zealand University Hospital, K&#xf8;ge, Denmark.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>11</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Transfusion</MedlineTA><NlmUniqueID>0417360</NlmUniqueID><ISSNLinking>0041-1132</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000017">ABO Blood-Group System</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001789">Blood Group Antigens</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000017" MajorTopicYN="N">ABO Blood-Group System</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001789" MajorTopicYN="Y">Blood Group Antigens</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="Y">Post-Acute COVID-19 Syndrome</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020022" MajorTopicYN="N">Genetic Predisposition to Disease</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ABO</Keyword><Keyword MajorTopicYN="N">COVID hospitalization</Keyword><Keyword MajorTopicYN="N">COVID severity</Keyword><Keyword MajorTopicYN="N">COVID susceptibility</Keyword><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Diego</Keyword><Keyword MajorTopicYN="N">Dombrock</Keyword><Keyword MajorTopicYN="N">Duffy</Keyword><Keyword MajorTopicYN="N">FUT2</Keyword><Keyword MajorTopicYN="N">FUT3</Keyword><Keyword MajorTopicYN="N">Kell</Keyword><Keyword MajorTopicYN="N">Kidd</Keyword><Keyword MajorTopicYN="N">Knops</Keyword><Keyword MajorTopicYN="N">Lewis</Keyword><Keyword MajorTopicYN="N">Lutheran</Keyword><Keyword MajorTopicYN="N">MNS</Keyword><Keyword MajorTopicYN="N">P1PK</Keyword><Keyword MajorTopicYN="N">Rh</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">Vel</Keyword><Keyword MajorTopicYN="N">Yt</Keyword><Keyword MajorTopicYN="N">blood antigen</Keyword><Keyword MajorTopicYN="N">blood groups</Keyword><Keyword MajorTopicYN="N">blood systems</Keyword><Keyword MajorTopicYN="N">long COVID symptoms</Keyword><Keyword MajorTopicYN="N">long COVID-19</Keyword><Keyword MajorTopicYN="N">secretor</Keyword></KeywordList><CoiStatement>Martin L Olsson and his spouse are inventors on patents about Vel blood group genotyping and own 50% each of the shares in BLUsang AB, an incorporated consulting firm which receives royalties for said patents. They are both co&#x2010;authors of AABB books and members of the Transfusion editorial board. Maria Didriksen received consultant fee for helping with a study tracking COVID&#x2010;19 infection among Falck Health Care Workers, which has no connection to the present study. All other authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>8</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>2</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>9</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>10</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>1</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>10</Month><Day>22</Day><Hour>0</Hour><Minute>28</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>11</Month><Day>3</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36271437</ArticleId><ArticleId IdType="pmc">PMC9874484</ArticleId><ArticleId IdType="doi">10.1111/trf.17170</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Zhao J, Yang Y, Huang H, et al. Relationship between the ABO blood group and the COVID&#x2010;19 susceptibility. medRxiv. 2020;19:54&#x2013;63. 10.1101/2020.03.11.20031096</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.03.11.20031096</ArticleId></ArticleIdList></Reference><Reference><Citation>Guti&#xe9;rrez&#x2010;Valencia M, Leache L, Librero J, Jeric&#xf3; C, Enguita Germ&#xe1;n M, Garc&#xed;a&#x2010;Erce JA. ABO blood group and risk of COVID&#x2010;19 infection and complications: a systematic review and meta&#x2010;analysis. Transfusion. 2021;62:493&#x2013;505. 10.1111/trf.16748</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/trf.16748</ArticleId><ArticleId IdType="pmc">PMC8661771</ArticleId><ArticleId IdType="pubmed">34773411</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y, Garner R, Salehi S, La Rocca M, Duncan D. Association between ABO blood types and coronavirus disease 2019 (COVID&#x2010;19), genetic associations, and underlying molecular mechanisms: a literature review of 23 studies. Ann Hematol. 2021;100:1123&#x2013;32.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7939543</ArticleId><ArticleId IdType="pubmed">33686492</ArticleId></ArticleIdList></Reference><Reference><Citation>Ellinghaus D, Degenhardt F, Bujanda L, et al. Genomewide association study of severe Covid&#x2010;19 with respiratory failure. N Engl J Med. 2020;383:1522&#x2013;34. 10.1056/NEJMoa2020283</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2020283</ArticleId><ArticleId IdType="pmc">PMC7315890</ArticleId><ArticleId IdType="pubmed">32558485</ArticleId></ArticleIdList></Reference><Reference><Citation>Barnkob MB, Potteg&#xe5;rd A, St&#xf8;vring H, Haunstrup TM, Homburg K, Larsen R, et al. Reduced prevalence of SARS&#x2010;CoV&#x2010;2 infection in ABO blood group O. Blood Adv. 2020;4:4990&#x2013;3.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7594382</ArticleId><ArticleId IdType="pubmed">33057631</ArticleId></ArticleIdList></Reference><Reference><Citation>Goel R, Bloch EM, Pirenne F, al&#x2010;Riyami AZ, Crowe E, Dau L, et al. ABO blood group and COVID&#x2010;19: a review on behalf of the ISBT COVID&#x2010;19 working group. Vox Sang. 2021;116:849&#x2013;61.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8014128</ArticleId><ArticleId IdType="pubmed">33578447</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamamoto F, Yamamoto M, Mu&#xf1;iz&#x2010;Diaz E. Blood group ABO polymorphism inhibits SARS&#x2010;CoV&#x2010;2 infection and affects COVID&#x2010;19 progression. Vox Sang. 2020;116:15&#x2013;7. 10.1111/vox.13004</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/vox.13004</ArticleId><ArticleId IdType="pmc">PMC7537232</ArticleId><ArticleId IdType="pubmed">32965025</ArticleId></ArticleIdList></Reference><Reference><Citation>Valenti L, Villa S, Baselli G, Temporiti R, Bandera A, Scudeller L, et al. Association of ABO blood group and secretor phenotype with severe COVID&#x2010;19. Transfusion. 2020;60:3067&#x2013;70.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7675339</ArticleId><ArticleId IdType="pubmed">33009662</ArticleId></ArticleIdList></Reference><Reference><Citation>Mankelow TJ, Singleton BK, Moura PL, Stevens&#x2010;Hernandez CJ, Cogan NM, Gyorffy G, et al. Blood group type a secretors are associated with a higher risk of COVID&#x2010;19 cardiovascular disease complications. EJHaem. 2021;2:175&#x2013;87.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8176350</ArticleId><ArticleId IdType="pubmed">34124710</ArticleId></ArticleIdList></Reference><Reference><Citation>Matzhold EM, Berghold A, Bemelmans MKB, Banfi C, Stelzl E, Kessler HH, et al. Lewis and ABO histo&#x2010;blood types and the secretor status of patients hospitalized with COVID&#x2010;19 implicate a role for ABO antibodies in susceptibility to infection with SARS&#x2010;CoV&#x2010;2. Transfusion. 2021;61:2736&#x2013;45.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8447157</ArticleId><ArticleId IdType="pubmed">34151460</ArticleId></ArticleIdList></Reference><Reference><Citation>Donskov SI, Bulanov AY, Simarova IB, Belyakova VV, Mayorova OA, Kravtsova EA, et al. AB0 and rhesus blood groups as a risk factor for ARVI COVID&#x2010;19. Klin Lab Diagn. 2021;66:661&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">34882350</ArticleId></ArticleIdList></Reference><Reference><Citation>Anderson JL, May HT, Knight S, Bair TL, Horne BD, Knowlton KU. Association of Rhesus factor blood type with risk of SARS&#x2010;CoV&#x2010;2 infection and COVID&#x2010;19 severity. Br J Haematol. 2022;197:573&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">35106763</ArticleId></ArticleIdList></Reference><Reference><Citation>Behboudi E, Hamidi V, Gholizadeh F, Grala EM, Ghelmani Y, Nakhaie M, et al. Association between ABO blood groups and rhesus antigen and susceptibility to COVID&#x2010;19 in the Yazd hospital. New Microbes New Infect. 2021;44:100934.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8409054</ArticleId><ArticleId IdType="pubmed">34484798</ArticleId></ArticleIdList></Reference><Reference><Citation>Kerbage A, Haddad SF, Nasr L, Riachy A, Mekhael E, Nassim N, et al. Impact of ABO and rhesus blood groups on COVID&#x2010;19 susceptibility and severity: a case&#x2010;control study. J Med Virol. 2021;94:1162&#x2013;6. 10.1002/jmv.27444</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.27444</ArticleId><ArticleId IdType="pmc">PMC8662239</ArticleId><ArticleId IdType="pubmed">34755349</ArticleId></ArticleIdList></Reference><Reference><Citation>Ray JG, Schull MJ, Vermeulen MJ, Park AL. Association between ABO and Rh blood groups and SARS&#x2010;CoV&#x2010;2 infection or severe COVID&#x2010;19 illness: a population&#x2010;based cohort study. Ann Intern Med. 2021;174:308&#x2013;15.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7711653</ArticleId><ArticleId IdType="pubmed">33226859</ArticleId></ArticleIdList></Reference><Reference><Citation>Hermel DJ, Spierling Bagsic SR, Costantini CL, Mason JR, Gahvari ZJ, Saven A. ABO phenotype and clinical correlates of COVID&#x2010;19 severity in hospitalized patients. Future Sci OA. 2021;7, FSO735. DOI: 10.3389/fmicb.2021.743048</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2021.743048</ArticleId><ArticleId IdType="pmc">PMC8204818</ArticleId><ArticleId IdType="pubmed">34290882</ArticleId></ArticleIdList></Reference><Reference><Citation>Greco S, Fabbri N, Bella A, Bonsi B, Violi A, Fortunato V, et al. COVID&#x2010;19 and blood groups: a six&#x2010;months observational study in Ferrara, Italy. Hematol Rep. 2021;13:9177.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8447536</ArticleId><ArticleId IdType="pubmed">34650783</ArticleId></ArticleIdList></Reference><Reference><Citation>Edgren G, Rostgaard K, Vasan SK, Wikman A, Norda R, Pedersen OB, et al. The new Scandinavian donations and transfusions database (SCANDAT2): a blood safety resource with added versatility. Transfusion. 2015;55:1600&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">25573303</ArticleId></ArticleIdList></Reference><Reference><Citation>Sch&#xf8;nning K, Dessau RB, Jensen TG, Thorsen NM, Wiuff C, Nielsen L, et al. Electronic reporting of diagnostic laboratory test results from all healthcare sectors is a cornerstone of national preparedness and control of COVID&#x2010;19 in Denmark. APMIS. 2021;129:438&#x2013;51.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8239934</ArticleId><ArticleId IdType="pubmed">33949007</ArticleId></ArticleIdList></Reference><Reference><Citation>Pedersen OB, Erikstrup C, Kotz&#xe9; SR, S&#xf8;rensen E, Petersen MS, Grau K, et al. The Danish blood donor study: a large, prospective cohort and biobank for medical research. Vox Sang. 2012;102:271.</Citation><ArticleIdList><ArticleId IdType="pubmed">21967299</ArticleId></ArticleIdList></Reference><Reference><Citation>Kindberg E, Hejdeman B, Bratt G, Wahren B, Lindblom B, Hinkula J, et al. A nonsense mutation (428G&#x2010;&#x2010;&gt;a) in the fucosyltransferase FUT2 gene affects the progression of HIV&#x2010;1 infection. AIDS. 2006;20:685&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">16514298</ArticleId></ArticleIdList></Reference><Reference><Citation>Rydell GE, Kindberg E, Larson G, Svensson L. Susceptibility to winter vomiting disease: a sweet matter. Rev Med Virol. 2011;21:370&#x2013;82.</Citation><ArticleIdList><ArticleId IdType="pubmed">22025362</ArticleId></ArticleIdList></Reference><Reference><Citation>Kelly RJ, Rouquier S, Giorgi D, Lennon GG, Lowe JB. Sequence and expression of a candidate for the human secretor blood group alpha(1,2)fucosyltransferase gene (FUT2). Homozygosity for an enzyme&#x2010;inactivating nonsense mutation commonly correlates with the non&#x2010;secretor phenotype. J Biol Chem. 1995;270:4640&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">7876235</ArticleId></ArticleIdList></Reference><Reference><Citation>Kabrah SM, Kabrah AM, Flemban AF, Abuzerr S. Systematic review and meta&#x2010;analysis of the susceptibility of ABO blood group to COVID&#x2010;19 infection. Transfus Apher Sci. 2021;60:103169.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8139534</ArticleId><ArticleId IdType="pubmed">34045120</ArticleId></ArticleIdList></Reference><Reference><Citation>Boudin L, Janvier F, Bylicki O, Dutasta F. ABO blood groups are not associated with the risk of acquiring SARS&#x2010;CoV&#x2010;2 infection in young adults. Haematologica. 2020;105:2841&#x2013;3.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7716357</ArticleId><ArticleId IdType="pubmed">33256383</ArticleId></ArticleIdList></Reference><Reference><Citation>Ellis PJI. Modelling suggests ABO histo&#x2010;incompatibility may substantially reduce SARS&#x2010;CoV&#x2010;2 transmission. Epidemics. 2021;35:100446.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7919530</ArticleId><ArticleId IdType="pubmed">33706041</ArticleId></ArticleIdList></Reference><Reference><Citation>Pendu JL, Breiman A, Rocher J, Dion M, Ruvo&#xeb;n&#x2010;Clouet N. ABO blood types and COVID&#x2010;19: spurious, anecdotal, or truly important relationships? A reasoned review of available data. Viruses. 2021;13:160.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7911989</ArticleId><ArticleId IdType="pubmed">33499228</ArticleId></ArticleIdList></Reference><Reference><Citation>Golding J, Northstone K, Miller LL, Davey Smith G, Pembrey M. Differences between blood donors and a population sample: implications for case&#x2010;control studies. Int J Epidemiol. 2013;42:1145&#x2013;56.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3781001</ArticleId><ArticleId IdType="pubmed">23825379</ArticleId></ArticleIdList></Reference><Reference><Citation>Schetelig J, Baldauf H, Wendler S, Heidenreich F, Real R, Kolditz M, et al. Blood group a epitopes do not facilitate entry of SARS&#x2010;CoV&#x2010;2. J Intern Med. 2021;290:223&#x2013;6. 10.1111/joim.13256</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/joim.13256</ArticleId><ArticleId IdType="pmc">PMC8014025</ArticleId><ArticleId IdType="pubmed">33501658</ArticleId></ArticleIdList></Reference><Reference><Citation>Rigas AS, Berkfors AA, Pedersen OB, S&#xf8;rensen E, Nielsen KR, Larsen MH, et al. Reduced ferritin levels in individuals with non&#x2010;O blood group: results from the Danish blood donor study. Transfusion. 2017;57:2914&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">28990200</ArticleId></ArticleIdList></Reference><Reference><Citation>Haschka D, Hoffmann A, Weiss G. Iron in immune cell function and host defense. Semin Cell Dev Biol. 2021;115:27&#x2013;36.</Citation><ArticleIdList><ArticleId IdType="pubmed">33386235</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohn CS, Delaney M, Johnson ST. Katz LM. Technical Manual. 2020:aaBB.</Citation></Reference><Reference><Citation>Nilsson J, Rydell GE, Le Pendu J, Larson G. Norwalk virus&#x2010;like particles bind specifically to a, H and difucosylated Lewis but not to B histo&#x2010;blood group active glycosphingolipids. Glycoconj J. 2009;26:1171&#x2013;80.</Citation><ArticleIdList><ArticleId IdType="pubmed">19387828</ArticleId></ArticleIdList></Reference><Reference><Citation>Lozniewski A, Haristoy X, Rasko DA, Hatier &#x154;, Pl&#xe9;nat F&#xb8;, Taylor DE, et al. Influence of Lewis antigen expression by helicobacter pylori on bacterial internalization by gastric epithelial cells. Infect Immun. 2003;71:2902&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC153228</ArticleId><ArticleId IdType="pubmed">12704166</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruvo&#xeb;n N, Le Pendu J. Genetic susceptibility to norovirus infection. Pathol Biol (Paris). 2013;61:28&#x2013;35.</Citation><ArticleIdList><ArticleId IdType="pubmed">23399413</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwartz S, Vergoulidou M, Schreier E, Loddenkemper C, Reinwald M, Schmidt&#x2010;Hieber M, et al. Norovirus gastroenteritis causes severe and lethal complications after chemotherapy and hematopoietic stem cell transplantation. Blood. 2011;117:5850&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7022229</ArticleId><ArticleId IdType="pubmed">21487110</ArticleId></ArticleIdList></Reference><Reference><Citation>Jabczyk M, Nowak J, Hudzik B, Zubelewicz&#x2010;Szkodzi&#x144;ska B. Microbiota and its impact on the immune system in COVID&#x2010;19&#x2010;a narrative review. J Clin Med. 2021;10:4537.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8509181</ArticleId><ArticleId IdType="pubmed">34640553</ArticleId></ArticleIdList></Reference><Reference><Citation>de Oliveira GLV, Oliveira CNS, Pinzan CF, de Salis LVV, Cardoso CR d B. Microbiota modulation of the gut&#x2010;lung Axis in COVID&#x2010;19. Front Immunol. 2021;12:635471.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7945592</ArticleId><ArticleId IdType="pubmed">33717181</ArticleId></ArticleIdList></Reference><Reference><Citation>Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373&#x2013;83.</Citation><ArticleIdList><ArticleId IdType="pubmed">3558716</ArticleId></ArticleIdList></Reference><Reference><Citation>Atsma F, Veldhuizen I, Verbeek A, de Kort W, de Vegt F. Healthy donor effect: its magnitude in health research among blood donors. Transfusion. 2011;51:1820&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">21342203</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaspersen KA, Pedersen OB, Petersen MS, Hjalgrim H, Rostgaard K, M&#xf8;ller BK, et al. Obesity and risk of infection: results from the Danish blood donor study. Epidemiology. 2015;26:580&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">25978794</ArticleId></ArticleIdList></Reference><Reference><Citation>Niavarani A, Poustchi H, Shayanrad A, Sharafkhah M, Mohammadi Z, Mansour&#x2010;Ghanaei F, et al. Dynamics of the COVID&#x2010;19 clinical findings and the serologic response. Front Microbiol. 2021;12. DOI: 10.3389/fmicb.2021.743048</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2021.743048</ArticleId><ArticleId IdType="pmc">PMC8529145</ArticleId><ArticleId IdType="pubmed">34690989</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>